Astrocytoma Drug Market is driven by advancements in targeted therapy
The Astrocytoma Drug Market encompasses a range of pharmaceutical products designed to treat astrocytoma, a malignant brain tumor originating from astrocytes. Key therapies include small-molecule inhibitors, monoclonal antibodies, and immunomodulators that work by targeting specific molecular pathways involved in tumor proliferation. These drugs offer advantages such as increased specificity,...
0 Comments 0 Shares 75 Views 0 Reviews